Dynamic Technology Lab’s Progenics Pharmaceuticals PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-14,421
Closed -$55K – 1507
2020
Q1
$55K Buy
+14,421
New +$62.1K 0.01% 939
2019
Q1
– Sell
-25,867
Closed -$108K – 1461
2018
Q4
$108K Buy
+25,867
New +$132K 0.02% 890
2017
Q1
– Sell
-16,596
Closed -$144K – 1394
2016
Q4
$144K Buy
+16,596
New +$123K 0.04% 776
2016
Q2
– Sell
-28,359
Closed -$123K – 1279
2016
Q1
$123K Buy
+28,359
New +$126K 0.03% 818
2015
Q3
– Sell
-18,500
Closed -$138K – 1131
2015
Q2
$138K Buy
+18,500
New +$112K 0.05% 674

Other funds holding PGNX

Dynamic Technology Lab's PGNX Position: Q2 2020 in Review

Dynamic Technology Lab sold out of Progenics Pharmaceuticals (PGNX) in Q2 2020, closing a stake of 14,421 shares — an estimated $55K sold.

Dynamic Technology Lab first reported a position in PGNX in Q2 2015 and held it in 5 quarters. The position peaked at $144K in Q4 2016. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Dynamic Technology Lab reported no remaining Progenics Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Dynamic Technology Lab sold 14,421 Progenics Pharmaceuticals shares in Q2 2020, an estimated $55K.
  • Dynamic Technology Lab first reported a position in Progenics Pharmaceuticals in Q2 2015 and held it in 5 quarters.
  • Dynamic Technology Lab's Progenics Pharmaceuticals position peaked at $144K in Q4 2016.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals as of Q2 2020.

Based on Dynamic Technology Lab's 13F filing for Q2 2020, filed 14 Aug 2020.